Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
Real-time Estimate Cboe Europe  -  07:17 2022-12-08 am EST
300.98 CHF   -0.07%
01:20aRoche Wins US FDA Nod For Cerebrospinal Fluid Assays To Diagnose Alzheimer's Disease
MT
01:01aRoche Alzheimer's disease Cerebrospinal Fluid (CSF) assays receive FDA clearance, supporting more accurate and timely diagnosis
GL
12/07Replimune, Roche to Develop RP3 in Colorectal Cancer, Hepatocellular Carcinoma
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
12/02/2022 12/05/2022 12/06/2022 12/07/2022 12/08/2022 Date
308.25(c) 309.55(c) 305.2(c) 301.2(c) 301.15 Last
933 796 1 224 798 895 057 1 888 633 319 934 Volume
-0.56% +0.42% -1.41% -1.31% -0.02% Change
More quotes
Estimated financial data (e)
Sales 2022 63 370 M 67 427 M 67 427 M
Net income 2022 14 790 M 15 737 M 15 737 M
Net Debt 2022 11 208 M 11 926 M 11 926 M
P/E ratio 2022 16,3x
Yield 2022 3,19%
Sales 2023 63 035 M 67 070 M 67 070 M
Net income 2023 15 206 M 16 180 M 16 180 M
Net Debt 2023 3 146 M 3 348 M 3 348 M
P/E ratio 2023 15,9x
Yield 2023 3,28%
Capitalization 248 B 264 B 264 B
EV / Sales 2022 4,09x
EV / Sales 2023 3,99x
Nbr of Employees 100 920
Free-Float 89,0%
More Financials
Company
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The... 
Read more
Sector
Pharmaceuticals
Calendar
12/10 | 10:30amPresentation
More about the company
Ratings of Roche Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A
More Ratings
All news about ROCHE HOLDING AG
01:20aRoche Wins US FDA Nod For Cerebrospinal Fluid Assays To Diagnose Alzheimer's Disease
MT
01:01aRoche Alzheimer's disease Cerebrospinal Fluid (CSF) assays receive FDA clearance, suppo..
GL
12/07Replimune, Roche to Develop RP3 in Colorectal Cancer, Hepatocellular Carcinoma
DJ
12/07Replimune Enters into Clinical Collaboration Agreement with Roche for the Development o..
CI
12/07Morgan Stanley Lowers Price Target on Roche, Maintains Equalweight Recommendation
MT
12/06BNP Paribas Lowers Price Target on Roche, Maintains Outperform Recommendation
MT
12/05Roche Diagnostics North America Announces Brad Moore as President, Effective January 1,..
CI
12/02Oncolytics Biotech Receives FDA Fast Track Designation for the Treatment of Advanced Me..
AQ
12/02ROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating
MD
12/01Roche Agrees To Launch Cancer Drug Production In Kazakhstan
MT
12/01Roche's Lung Cancer Drug Tecentriq Shown Effective as Subcutaneous Injection in Late-St..
MT
11/30Roche's Alzheimer's Drug Found to be Less Effective in Clearing Toxic Protein from Brai..
MT
11/29Sarepta Therapeutics Announces That U.S. FDA has Accepted for Filing and Granted Priori..
AQ
11/29India's Gland Pharma to buy Cenexi for $124 mln in Europe push
RE
11/28Sarepta-Roche Rare Muscle Disorder Drug Granted US FDA Priority Review
MT
More news
News in other languages on ROCHE HOLDING AG
06:55aMÄRKTE EUROPA/Börsen drehen leicht ins Minus - Stahlwerte gesucht
06:14aRoche: via libera negli Usa a test per diagnosticare l'Alzheimer
05:27aRoche erhält US-Zulassung für Alzheimer-Test
03:35aEN DIRECTO DESDE LOS MERCADOS: Iberdrola, Sacyr, Enel, Sch..
03:33aMÄRKTE EUROPA/Behauptet - Positive Inflationssignale
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Stock Trading Strategies
ROCHE HOLDING AG - 03/18
There is still some upside potential
BUY
More Stock Trading Analysis
ETFs positioned on ROCHE HOLDING AGETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
UBS ETF (CH) - SMI A-dis - CHF19.02%0.37%Switzerland
IShares SMI (CH) - CHF18.8%0.31%Switzerland
SPDR MSCI Europe Health Care - EUR18.7%0.68%-NC
IShares MSCI Europe Health Care Sector Acc - EUR18.65%0.08%-NC
Xtrackers Switzerland - 1C - CHF18.59%0.18%Switzerland
More ETFs positioned on ROCHE HOLDING AG
Analysis
Roche's Alzheimer's drug fails to meet goal in long awaited trial
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 301,20 CHF
Average target price 371,04 CHF
Spread / Average Target 23,2%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Officer
Christoph Franz Chairman
Levi A. Garraway Chief Medical Officer
Pascale Schmidt Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG-20.55%264 164
JOHNSON & JOHNSON2.94%463 208
ELI LILLY AND COMPANY33.42%353 438
ABBVIE INC.22.16%292 407
NOVO NORDISK A/S20.94%283 266
PFIZER, INC.-15.82%282 013